These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23185183)

  • 21. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
    Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
    Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of cancer ratio for malignant pleural effusion: a systematic review and meta-analysis.
    Han YQ; Zhang L; Yan L; Ouyang PH; Li P; Hu ZD
    Ann Transl Med; 2019 Oct; 7(20):554. PubMed ID: 31807535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
    Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
    Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
    Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
    Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
    Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
    Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.
    Shin YM; Yun J; Lee OJ; Han HS; Lim SN; An JY; Lee KH; Lee KM; Choe KH
    Cancer Res Treat; 2014 Apr; 46(2):178-85. PubMed ID: 24851110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results.
    Antonangelo L; Sales RK; Corá AP; Acencio MM; Teixeira LR; Vargas FS
    Curr Oncol; 2015 Oct; 22(5):e336-41. PubMed ID: 26628873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
    Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
    Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.
    Alataş F; Alataş O; Metintaş M; Colak O; Harmanci E; Demir S
    Lung Cancer; 2001 Jan; 31(1):9-16. PubMed ID: 11162861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis.
    Kassirian S; Hinton SN; Cuninghame S; Chaudhary R; Iansavitchene A; Amjadi K; Dhaliwal I; Zeman-Pocrnich C; Mitchell MA
    Thorax; 2023 Jan; 78(1):32-40. PubMed ID: 35110369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review.
    Tozzoli R; Basso SM; D'Aurizio F; Metus P; Lumachi F
    Clin Biochem; 2016 Nov; 49(16-17):1227-1231. PubMed ID: 27521620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
    Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
    J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
    Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
    Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine: new tumor marker in pleural fluid.
    Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
    Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis.
    Wu Q; Li M; Zhang S; Chen L; Gu X; Xu F
    Exp Ther Med; 2015 Jan; 9(1):232-238. PubMed ID: 25452808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.
    Lee SH; Park MJ; Choi SI; Lee EJ; Lee SY; In KH
    Medicine (Baltimore); 2017 Jan; 96(4):e5975. PubMed ID: 28121949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.